CG Oncology, Inc.
CGONFigures shown here come from public SEC filings. Dates beside each section show the available history.
How CG Oncology, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Virtus Investment Advisers, LLC | 2026-03-31 | 6,660 | $451K | SEC filing |
| Hudson Bay Capital Management LP | 2026-03-31 | 7,480 | $506K | SEC filing |
| Manchester Capital Management LLC | 2026-03-31 | 22 | $1.49K | SEC filing |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 2026-03-31 | 6,373 | $430K | SEC filing |
| Ensign Peak Advisors, Inc | 2026-03-31 | 456,012 | $30.9M | SEC filing |
| ABS Direct Equity Fund LLC | 2026-03-31 | 2,600 | $176K | SEC filing |
| Sanctuary Advisors, LLC | 2026-03-31 | 6,237 | $422K | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 163,172 | $11M | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 5,359 | $363K | SEC filing |
| Advisory Services Network, LLC | 2026-03-31 | 5 | $338 | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 187,765 | $12.7M | SEC filing |
| ACORN CAPITAL ADVISORS, LLC | 2026-03-31 | 1,130,501 | $76.6M | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 18,089 | $1.22M | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 2,728 | $185K | SEC filing |
| VOYA INVESTMENT MANAGEMENT LLC | 2026-03-31 | 57,291 | $3.88M | SEC filing |
| TD Asset Management Inc | 2026-03-31 | 288,756 | $19.5M | SEC filing |
| ARIZONA STATE RETIREMENT SYSTEM | 2026-03-31 | 11,747 | $795K | SEC filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 2026-03-31 | 159 | $10.8K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 1,159,239 | $78.5M | SEC filing |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2026-03-31 | 166,349 | $11.3M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among CG Oncology, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-09-03 · Song Hong Fang: Larger than 35 of the 38 other insider sales of Common Stock on file. SEC filing
- 2024-12-16 · Song Hong Fang: Larger than all 38 other insider sales of Common Stock on file. SEC filing
- 2024-08-29 · Song Hong Fang: Larger than 36 of the 38 other insider sales of Common Stock on file. SEC filing
- 2024-08-29 · Song Hong Fang: Larger than 37 of the 38 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-25 | Liu Brian Guan-Chyun · Director | Common Stock | P — Open market or private purchase | +371,085 | 66.87 | SEC filing |
| 2026-06-24 | POST LEONARD E · Director | Common Stock | S — Open market or private sale | −5,000 | 70.00 | SEC filing |
| 2026-06-22 | POST LEONARD E · Director | Common Stock | S — Open market or private sale | −5,000 | 65.00 | SEC filing |
| 2026-06-15 | Mulay James · Director | Common Stock | S — Open market or private sale | −1,310 | 60.12 | SEC filing |
| 2026-06-15 | Mulay James · Director | Common Stock | S — Open market or private sale | −654 | 60.12 | SEC filing |
| 2026-06-04 | POST LEONARD E · Director | Common Stock | S — Open market or private sale | −1,000 | 54.50 | SEC filing |
| 2026-04-17 | Mulay James · Director | Common Stock | S — Open market or private sale | −15,600 | 73.01 | SEC filing |
| 2026-03-16 | Mulay James · Director | Common Stock | S — Open market or private sale | −654 | 63.50 | SEC filing |
Showing 8 of 17 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-24 | POST LEONARD E · Director | Director Stock Option (right to buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
| 2026-06-24 | POST LEONARD E · Director | Common Stock | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-06-22 | POST LEONARD E · Director | Director Stock Option (right to buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
| 2026-06-22 | POST LEONARD E · Director | Common Stock | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-06-15 | Mulay James · Director | Director Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,310 | SEC filing |
| 2026-06-15 | Mulay James · Director | Common Stock | M — Exercise or conversion of derivative security | +1,310 | SEC filing |
| 2026-06-15 | Mulay James · Director | Common Stock | M — Exercise or conversion of derivative security | +654 | SEC filing |
| 2026-06-15 | Mulay James · Director | Director Stock Option (right to buy) | M — Exercise or conversion of derivative security | −654 | SEC filing |
Showing 8 of 22 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.